The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Positive Patient Identification (PPID) Market Research Report 2025
Synopsis
Positive patient identification refers to a combination of hardware and software solutions designed for identifying a patient’s details so as to ensure correct medication is provided to the same.
The global Positive Patient Identification (PPID) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Positive Patient Identification (PPID) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Positive Patient Identification (PPID) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Positive Patient Identification (PPID) in Web Based is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Positive Patient Identification (PPID) include Imprivata, Inc., RightPatient, Inc., General Data Company, Inc., GBS Corporation, MSoft eSolutions Ltd., PatientWorks Corporation, SATO Holdings Corporation, Zebra Technologies and RMS Omega Technologies Group, Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Positive Patient Identification (PPID), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Positive Patient Identification (PPID).
Report Scope
The Positive Patient Identification (PPID) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Positive Patient Identification (PPID) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Positive Patient Identification (PPID) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Imprivata, Inc.
RightPatient, Inc.
General Data Company, Inc.
GBS Corporation
MSoft eSolutions Ltd.
PatientWorks Corporation
SATO Holdings Corporation
Zebra Technologies
RMS Omega Technologies Group, Inc.
Segment by Type
Scanning Devices
Software
Services
Segment by Application
Web Based
Cloud Based
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Positive Patient Identification (PPID) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Positive patient identification refers to a combination of hardware and software solutions designed for identifying a patient’s details so as to ensure correct medication is provided to the same.
The global Positive Patient Identification (PPID) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Positive Patient Identification (PPID) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Positive Patient Identification (PPID) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Positive Patient Identification (PPID) in Web Based is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Positive Patient Identification (PPID) include Imprivata, Inc., RightPatient, Inc., General Data Company, Inc., GBS Corporation, MSoft eSolutions Ltd., PatientWorks Corporation, SATO Holdings Corporation, Zebra Technologies and RMS Omega Technologies Group, Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Positive Patient Identification (PPID), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Positive Patient Identification (PPID).
Report Scope
The Positive Patient Identification (PPID) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Positive Patient Identification (PPID) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Positive Patient Identification (PPID) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Imprivata, Inc.
RightPatient, Inc.
General Data Company, Inc.
GBS Corporation
MSoft eSolutions Ltd.
PatientWorks Corporation
SATO Holdings Corporation
Zebra Technologies
RMS Omega Technologies Group, Inc.
Segment by Type
Scanning Devices
Software
Services
Segment by Application
Web Based
Cloud Based
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Positive Patient Identification (PPID) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Positive Patient Identification (PPID) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Scanning Devices
1.2.3 Software
1.2.4 Services
1.3 Market by Application
1.3.1 Global Positive Patient Identification (PPID) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Web Based
1.3.3 Cloud Based
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Positive Patient Identification (PPID) Market Perspective (2019-2030)
2.2 Positive Patient Identification (PPID) Growth Trends by Region
2.2.1 Global Positive Patient Identification (PPID) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Positive Patient Identification (PPID) Historic Market Size by Region (2019-2024)
2.2.3 Positive Patient Identification (PPID) Forecasted Market Size by Region (2025-2030)
2.3 Positive Patient Identification (PPID) Market Dynamics
2.3.1 Positive Patient Identification (PPID) Industry Trends
2.3.2 Positive Patient Identification (PPID) Market Drivers
2.3.3 Positive Patient Identification (PPID) Market Challenges
2.3.4 Positive Patient Identification (PPID) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Positive Patient Identification (PPID) Players by Revenue
3.1.1 Global Top Positive Patient Identification (PPID) Players by Revenue (2019-2024)
3.1.2 Global Positive Patient Identification (PPID) Revenue Market Share by Players (2019-2024)
3.2 Global Positive Patient Identification (PPID) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Positive Patient Identification (PPID) Revenue
3.4 Global Positive Patient Identification (PPID) Market Concentration Ratio
3.4.1 Global Positive Patient Identification (PPID) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Positive Patient Identification (PPID) Revenue in 2023
3.5 Positive Patient Identification (PPID) Key Players Head office and Area Served
3.6 Key Players Positive Patient Identification (PPID) Product Solution and Service
3.7 Date of Enter into Positive Patient Identification (PPID) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Positive Patient Identification (PPID) Breakdown Data by Type
4.1 Global Positive Patient Identification (PPID) Historic Market Size by Type (2019-2024)
4.2 Global Positive Patient Identification (PPID) Forecasted Market Size by Type (2025-2030)
5 Positive Patient Identification (PPID) Breakdown Data by Application
5.1 Global Positive Patient Identification (PPID) Historic Market Size by Application (2019-2024)
5.2 Global Positive Patient Identification (PPID) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Positive Patient Identification (PPID) Market Size (2019-2030)
6.2 North America Positive Patient Identification (PPID) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Positive Patient Identification (PPID) Market Size by Country (2019-2024)
6.4 North America Positive Patient Identification (PPID) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Positive Patient Identification (PPID) Market Size (2019-2030)
7.2 Europe Positive Patient Identification (PPID) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Positive Patient Identification (PPID) Market Size by Country (2019-2024)
7.4 Europe Positive Patient Identification (PPID) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Positive Patient Identification (PPID) Market Size (2019-2030)
8.2 Asia-Pacific Positive Patient Identification (PPID) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Positive Patient Identification (PPID) Market Size by Region (2019-2024)
8.4 Asia-Pacific Positive Patient Identification (PPID) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Positive Patient Identification (PPID) Market Size (2019-2030)
9.2 Latin America Positive Patient Identification (PPID) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Positive Patient Identification (PPID) Market Size by Country (2019-2024)
9.4 Latin America Positive Patient Identification (PPID) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Positive Patient Identification (PPID) Market Size (2019-2030)
10.2 Middle East & Africa Positive Patient Identification (PPID) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Positive Patient Identification (PPID) Market Size by Country (2019-2024)
10.4 Middle East & Africa Positive Patient Identification (PPID) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Imprivata, Inc.
11.1.1 Imprivata, Inc. Company Detail
11.1.2 Imprivata, Inc. Business Overview
11.1.3 Imprivata, Inc. Positive Patient Identification (PPID) Introduction
11.1.4 Imprivata, Inc. Revenue in Positive Patient Identification (PPID) Business (2019-2024)
11.1.5 Imprivata, Inc. Recent Development
11.2 RightPatient, Inc.
11.2.1 RightPatient, Inc. Company Detail
11.2.2 RightPatient, Inc. Business Overview
11.2.3 RightPatient, Inc. Positive Patient Identification (PPID) Introduction
11.2.4 RightPatient, Inc. Revenue in Positive Patient Identification (PPID) Business (2019-2024)
11.2.5 RightPatient, Inc. Recent Development
11.3 General Data Company, Inc.
11.3.1 General Data Company, Inc. Company Detail
11.3.2 General Data Company, Inc. Business Overview
11.3.3 General Data Company, Inc. Positive Patient Identification (PPID) Introduction
11.3.4 General Data Company, Inc. Revenue in Positive Patient Identification (PPID) Business (2019-2024)
11.3.5 General Data Company, Inc. Recent Development
11.4 GBS Corporation
11.4.1 GBS Corporation Company Detail
11.4.2 GBS Corporation Business Overview
11.4.3 GBS Corporation Positive Patient Identification (PPID) Introduction
11.4.4 GBS Corporation Revenue in Positive Patient Identification (PPID) Business (2019-2024)
11.4.5 GBS Corporation Recent Development
11.5 MSoft eSolutions Ltd.
11.5.1 MSoft eSolutions Ltd. Company Detail
11.5.2 MSoft eSolutions Ltd. Business Overview
11.5.3 MSoft eSolutions Ltd. Positive Patient Identification (PPID) Introduction
11.5.4 MSoft eSolutions Ltd. Revenue in Positive Patient Identification (PPID) Business (2019-2024)
11.5.5 MSoft eSolutions Ltd. Recent Development
11.6 PatientWorks Corporation
11.6.1 PatientWorks Corporation Company Detail
11.6.2 PatientWorks Corporation Business Overview
11.6.3 PatientWorks Corporation Positive Patient Identification (PPID) Introduction
11.6.4 PatientWorks Corporation Revenue in Positive Patient Identification (PPID) Business (2019-2024)
11.6.5 PatientWorks Corporation Recent Development
11.7 SATO Holdings Corporation
11.7.1 SATO Holdings Corporation Company Detail
11.7.2 SATO Holdings Corporation Business Overview
11.7.3 SATO Holdings Corporation Positive Patient Identification (PPID) Introduction
11.7.4 SATO Holdings Corporation Revenue in Positive Patient Identification (PPID) Business (2019-2024)
11.7.5 SATO Holdings Corporation Recent Development
11.8 Zebra Technologies
11.8.1 Zebra Technologies Company Detail
11.8.2 Zebra Technologies Business Overview
11.8.3 Zebra Technologies Positive Patient Identification (PPID) Introduction
11.8.4 Zebra Technologies Revenue in Positive Patient Identification (PPID) Business (2019-2024)
11.8.5 Zebra Technologies Recent Development
11.9 RMS Omega Technologies Group, Inc.
11.9.1 RMS Omega Technologies Group, Inc. Company Detail
11.9.2 RMS Omega Technologies Group, Inc. Business Overview
11.9.3 RMS Omega Technologies Group, Inc. Positive Patient Identification (PPID) Introduction
11.9.4 RMS Omega Technologies Group, Inc. Revenue in Positive Patient Identification (PPID) Business (2019-2024)
11.9.5 RMS Omega Technologies Group, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
